MENU

How you could have turned $10,000 into $370,000 in five years on the ASX

The share market has been a great place to invest your money over the last five years. During this time the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) has delivered an average return of approximately 7.1% per annum.

This means that a $10,000 investment in the index five years ago would have grown to be worth just over $14,000 today.

Whilst this is a solid return in such a short space of time, it pales in comparison to some of the returns that have been made on the market.

The following seven shares have beaten the market by some distance over the period:

The A2 Milk Company Ltd (ASX: A2M) share price has been trading on the ASX for just under four years. If you’d picked up $10,000 worth of shares in April 2015 at 56 cents, that investment would have grown to be worth $247,000 today.

The Altium Limited (ASX: ALU) share price has provided a total return of approximately 74.1% per annum over the last five years. This would have turned a $10,000 investment into $160,000.

The Appen Ltd (ASX: APX) share price has been trading on the ASX since January 2015. If you picked up $10,000 worth of the shares of the developer of high-quality, human annotated datasets that month for 63 cents, that investment would now be worth $373,000.

The Bellamy’s Australia Ltd (ASX: BAL) share price has been a big mover since hitting the ASX boards in August 2014. So much so, a $10,000 investment in the infant formula company’s shares that month would now be worth a cool $66,000.

The Clinuvel Pharmaceuticals Limited (ASX: CUV) share price has provided investors with an average total return of 74.9% per annum over the last five years. This means that a $10,000 investment in the pharmaceutical company’s shares five years ago would be worth almost $164,000 today.

The Nanosonics Ltd (ASX: NAN) share price has been a strong performer over the last five years, providing shareholders with an average total return of 37.1% annum. This would have turned a $10,000 investment in the infection control specialist’s shares five years ago into $48,500 today.

The Pro Medicus Limited (ASX: PME) share price has provided investors with a staggering average annual return of 81.9% per annum over the last five years. Which means $10,000 invested in the healthcare technology company’s shares would have grown to be worth $199,000.

Foolish Takeaway.

Whilst returns of this nature are reasonably rare, they do happen, and I feel confident in five years we’ll be looking back at another group of shares that have done the same.

The key will be finding these shares before they take off.

Luckily our expert analysts are busy looking for the next growth stars and recently picked out three to buy in 2019.

Top 3 ASX Blue Chips To Buy For 2019

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked...

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2019."

Each one pays a fully franked dividend. The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies move – we may be forced to remove this report.

Click here to claim your free report.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. recommends Pro Medicus Ltd. The Motley Fool Australia owns shares of and has recommended Nanosonics Limited and Pro Medicus Ltd. The Motley Fool Australia owns shares of A2 Milk, Altium, and Appen Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…

Including:

The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!